DAVIS, Calif.--(BUSINESS WIRE)--Vitalea Science (VS) today announced the appointment Dr. Robert Ings to its Scientific Advisory Board. Dr Ings brings an impressive resume covering 30 plus years in Europe and U.S. Pharmaceutical companies and, until recently, served as Vice President of DMPK at Roche Palo Alto. He presently is founder and President of RMI-Pharmacokinetics, a pharmaceutical consultancy firm grounded by his many years of experience in bringing effective drugs to market.
